カテゴリ： MarketLine, インドネシア, 企業調査

PT. Bank Rakyat Indonesia (Persero) Tbk.：戦略・SWOT・企業財務分析

◆英語タイトル：PT. Bank Rakyat Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8014795
◆発行会社（調査会社）：MarketLine
◆発行日：2017年11月13日
◆ページ数：35
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：インドネシア
◆産業分野：金融サービス
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

PT. Bank Rakyat Indonesia (Persero) Tbk. – Strategy, SWOT and Corporate Finance Report
Summary

PT. Bank Rakyat Indonesia (Persero) Tbk. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

PT. Bank Rakyat Indonesia (Persero) (BRI) is engaged in providing banking services. The bank provides consumer banking, investment banking, priority banking, e-banking, and financial services. The bank operates in Asia and the US. It is headquartered in Jakarta, Indonesia.

Scope

- Detailed information on PT. Bank Rakyat Indonesia (Persero) Tbk. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PT. Bank Rakyat Indonesia (Persero) Tbk. in the form of a SWOT analysis
- An in-depth view of the business model of PT. Bank Rakyat Indonesia (Persero) Tbk. including a breakdown and examination of key business segments
- Intelligence on PT. Bank Rakyat Indonesia (Persero) Tbk.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PT. Bank Rakyat Indonesia (Persero) Tbk., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of PT. Bank Rakyat Indonesia (Persero) Tbk. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PT. Bank Rakyat Indonesia (Persero) Tbk. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on PT. Bank Rakyat Indonesia (Persero) Tbk.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
PT. Bank Rakyat Indonesia (Persero) Tbk.: Company Overview
PT. Bank Rakyat Indonesia (Persero) Tbk.: Overview and Key Facts
PT. Bank Rakyat Indonesia (Persero) Tbk.: Overview
PT. Bank Rakyat Indonesia (Persero) Tbk.: Key Facts
PT. Bank Rakyat Indonesia (Persero) Tbk.: Key Employees
PT. Bank Rakyat Indonesia (Persero) Tbk.: Key Employee Biographies
PT. Bank Rakyat Indonesia (Persero) Tbk.: Major Products and Services
PT. Bank Rakyat Indonesia (Persero) Tbk.: Company History
PT. Bank Rakyat Indonesia (Persero) Tbk.: Management Statement
PT. Bank Rakyat Indonesia (Persero) Tbk.: Locations and Subsidiaries
PT. Bank Rakyat Indonesia (Persero) Tbk.: Key Competitors
PT. Bank Rakyat Indonesia (Persero) Tbk.: Company Analysis
PT. Bank Rakyat Indonesia (Persero) Tbk.: Business Description
PT. Bank Rakyat Indonesia (Persero) Tbk.: SWOT Analysis
PT. Bank Rakyat Indonesia (Persero) Tbk.: SWOT Overview
PT. Bank Rakyat Indonesia (Persero) Tbk.: Strengths
PT. Bank Rakyat Indonesia (Persero) Tbk.: Weaknesses
PT. Bank Rakyat Indonesia (Persero) Tbk.: Opportunities
PT. Bank Rakyat Indonesia (Persero) Tbk.: Threats
PT. Bank Rakyat Indonesia (Persero) Tbk.: Recent Developments
PT. Bank Rakyat Indonesia (Persero) Tbk.: News and Events Summary
PT. Bank Rakyat Indonesia (Persero) Tbk.: Business Expansion
PT. Bank Rakyat Indonesia (Persero) Tbk.: Contracts
PT. Bank Rakyat Indonesia (Persero) Tbk.: Corporate Governance
PT. Bank Rakyat Indonesia (Persero) Tbk.: Market Developments
PT. Bank Rakyat Indonesia (Persero) Tbk.: Regulatory and Legal Events
PT. Bank Rakyat Indonesia (Persero) Tbk.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: PT. Bank Rakyat Indonesia (Persero) Tbk.: Key Facts
Table 2: PT. Bank Rakyat Indonesia (Persero) Tbk.: Key Employees
Table 3: PT. Bank Rakyat Indonesia (Persero) Tbk.: Locations and Subsidiaries
Table 4: PT. Bank Rakyat Indonesia (Persero) Tbk.: Key Competitors
Table 5: PT. Bank Rakyat Indonesia (Persero) Tbk.: News and Events Summary
Table 6: PT. Bank Rakyat Indonesia (Persero) Tbk.: Business Expansion
Table 7: PT. Bank Rakyat Indonesia (Persero) Tbk.: Contracts
Table 8: PT. Bank Rakyat Indonesia (Persero) Tbk.: Corporate Governance
Table 9: PT. Bank Rakyat Indonesia (Persero) Tbk.: Market Developments
Table 10: PT. Bank Rakyat Indonesia (Persero) Tbk.: Regulatory and Legal Events
Table 11: PT. Bank Rakyat Indonesia (Persero) Tbk.: Strategy and Operations

★海外企業調査レポート[PT. Bank Rakyat Indonesia (Persero) Tbk.：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • The Depository Trust & Clearing Corporation：企業の戦略的SWOT分析
    The Depository Trust & Clearing Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Torque Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Torque Therapeutics Inc (Torque) is an immuno-oncology company focused on developing first-in-class deep primed T Cell therapeutics to cure cancer. Its product pipeline includes Deep IL-15 used for for hematologic and solid tumors; Deep IL-12 targeting solid tumors; and small-molecule Deep T …
  • mAbxience SA：製薬・医療：M&Aディール及び事業提携情報
    Summary Mabxience SA (mAbxience), a subsidiary of Chemo Espana SA, is a biotechnology company that research, develops and manufactures biosimilar monoclonal antibodies. The company develops biosimilars, which are used for the treatment and prevention of various diseases in onclology such as breast c …
  • DZ HYP AG：企業の戦略・SWOT・財務分析
    DZ HYP AG - Strategy, SWOT and Corporate Finance Report Summary DZ HYP AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • KPC Pharmaceuticals Inc (600422)-製薬・医療分野：企業M&A・提携分析
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and botanical drugs. It also offers drugs such as xue …
  • SomaLogic Inc：企業の製品パイプライン分析2018
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …
  • Indian Oil Corporation Limited：企業の戦略・SWOT・財務分析
    Indian Oil Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Indian Oil Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ultragenyx Pharmaceutical Inc (RARE)：企業の財務・戦略的SWOT分析
    Ultragenyx Pharmaceutical Inc (RARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Repsol SA (REP)：石油・ガス：M&Aディール及び事業提携情報
    Summary Repsol SA (Repsol) is an integrated oil and gas company. It has presence across the entire value chain: exploration and production, transformation, development and marketing of energy. The company’s upstream business carries out oil and natural gas exploration and production. Its downstream …
  • Gibson Energy Inc (GEI)：企業の財務・戦略的SWOT分析
    Gibson Energy Inc (GEI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Monsanto Co (MON)：企業の財務・戦略的SWOT分析
    Monsanto Co (MON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PT Pembangkitan Jawa-Bali：企業の戦略的SWOT分析
    PT Pembangkitan Jawa-Bali - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Richard Wolf GmbH：企業の戦略的SWOT分析
    Richard Wolf GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • GlycoNex Inc (4168)：製薬・医療：M&Aディール及び事業提携情報
    Summary GlycoNex Inc (GlycoNex) is a drug discovery company that conducts research and development in glycosphingolipid antigen and human monoclonal antibody technologies to develop cancer drugs. The company carries out antibody drug development through its various technology platforms such as glyco …
  • Frasers Property Limited：企業の戦略・SWOT・財務情報
    Frasers Property Limited - Strategy, SWOT and Corporate Finance Report Summary Frasers Property Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • One Medical Group Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary One Medical Group Inc (One Medical) is a provider of medical and technology-enabled health care services. The company’s service offerings include primary and pediatric care, prenatal and women's health, nutrition and sports medicine, LGBT care, mental health, dermatology, family and integrat …
  • Annexon Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Annexon Inc (Annexon) is a developer of therapeutic products and pathway inhibitors for the treatment of neurological disorders. The company develops treatments for Huntington’s disease and Alzheimer’s disease by targeting complement-mediated neurodegeneration. Its lead drug candidates inclu …
  • TOTAL S.A.：企業のM&A・事業提携・投資動向
    TOTAL S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TOTAL S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Inova Diagnostics Inc：医療機器：M&Aディール及び事業提携情報
    Summary Inova Diagnostics Inc (Inova), a subsidiary of Werfen Life Group SAU is a medical device company that develops and commercializes new autoimmune technologies and diagnostic markers. The company's diagnostic reagent products include quanta flash used for semi-quantitative determination of aut …
  • Malaysia Airlines Berhad：企業の戦略・SWOT・財務情報
    Malaysia Airlines Berhad - Strategy, SWOT and Corporate Finance Report Summary Malaysia Airlines Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆